GO:0047820 D-glutamate cyclase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0047820 D-glutamate cyclase activity catalyzes the reversible conversion of D-glutamate to 5-oxo-D-proline and water.
• The enzyme is a pyridoxal 5'-phosphate (PLP)-independent cyclase that belongs to the metallo-dependent hydrolase superfamily.
• Mammalian D-glutamate cyclase is highly expressed in liver, kidney, and heart, where it regulates D-glutamate levels.
• D-glutamate cyclase activity is essential for D-glutamate homeostasis and is linked to neurological and metabolic disorders.
• Colorimetric assays enable sensitive measurement of D-glutamate cyclase activity in biological samples.
• D-glutamate cyclase can be studied using CRISPR knockout, point mutation, and overexpression models to dissect its physiological roles.
Description
D-glutamate cyclase activity (GO:0047820) is a molecular function that catalyzes the cyclization of D-glutamate to 5-oxo-D-proline and water. This reaction is a key step in D-glutamate metabolism, a process that has gained attention because D-glutamate is a signaling molecule in the mammalian brain and periphery. The enzyme responsible for this activity, D-glutamate cyclase, is a PLP-independent enzyme that belongs to the metallo-dependent hydrolase superfamily. Understanding this activity is crucial for researchers studying D-amino acid metabolism, neurotransmission, and related diseases. The reaction is reversible and can be measured using a colorimetric assay that detects 5-oxo-D-proline formation. D-glutamate cyclase is distinct from other D-glutamate-metabolizing enzymes such as D-aspartate oxidase, which can also act on D-glutamate but with different substrate specificity. The enzyme's tissue distribution and kinetic properties have been characterized in mammals, revealing high activity in liver, kidney, and heart. This article provides a comprehensive overview of GO:0047820, including its mechanism, key genes, disease associations, and research methods, with a focus on CRISPR-based models for functional studies.
D-glutamate cyclase activity At A Glance
| GO ID | GO:0047820 |
|---|---|
| GO term | D-glutamate cyclase activity |
| Ontology | molecular_function |
| Synonym | D-glutamate hydro-lyase (cyclizing), D-glutamate hydro-lyase (cyclizing; 5-oxo-D-proline-forming) |
| Major function | Catalyzes the reversible conversion of D-glutamate to 5-oxo-D-proline and water |
| Cofactor | PLP-independent; no known cofactor required |
| Enzyme family | Metallo-dependent hydrolase superfamily |
| Tissue distribution | Highly expressed in liver, kidney, and heart |
| Assay method | Colorimetric assay measuring 5-oxo-D-proline formation |
What Is GO:0047820?
D-glutamate cyclase activity (GO:0047820) is defined as the catalysis of the reaction: D-glutamate = 5-oxo-D-proline + H2O. In other words, it is the enzyme activity that removes a water molecule from D-glutamate to form a cyclic product, 5-oxo-D-proline. This activity is also known as D-glutamate hydro-lyase (cyclizing) or D-glutamate hydro-lyase (cyclizing; 5-oxo-D-proline-forming). The reaction is reversible and does not require pyridoxal 5'-phosphate (PLP) as a cofactor, distinguishing it from many other amino acid racemases and dehydratases.
Why Is D-glutamate cyclase activity Important in Cell Biology?
D-glutamate cyclase activity is important because it regulates the cellular levels of D-glutamate, a D-amino acid with neuromodulatory and metabolic roles. Dysregulation of D-glutamate metabolism has been implicated in neurological and metabolic disorders, making this enzyme a potential therapeutic target. Moreover, the enzyme provides a unique example of a PLP-independent cyclase, offering insights into enzyme evolution and catalytic diversity. Studying this activity also helps distinguish it from other D-glutamate-metabolizing enzymes like D-aspartate oxidase, which can interfere with D-glutamate measurements.
• Regulates D-glutamate homeostasis in mammalian tissues.
• Linked to neurological disorders due to D-glutamate's role as a neurotransmitter.
• Provides a PLP-independent mechanism for amino acid cyclization.
• Enables accurate measurement of D-glutamate in biological samples when combined with specific assays.
• Potential target for metabolic diseases involving D-amino acid metabolism.
• Distinct from D-aspartate oxidase, which also acts on D-glutamate but with different kinetics.
• Useful for studying enzyme evolution and catalytic mechanisms.
• Can be studied using CRISPR models to dissect its physiological functions.
Molecular Mechanism of D-glutamate cyclase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs D-glutamate and holds it in place for the reaction.
D-glutamate cyclase specifically recognizes D-glutamate, the D-enantiomer of glutamate, while showing little or no activity toward L-glutamate or other amino acids. The substrate binding site is located in a cleft within the metallo-dependent hydrolase fold, and binding is mediated by hydrogen bonds and electrostatic interactions with the amino and carboxyl groups of D-glutamate. This specificity ensures that only D-glutamate is cyclized, preventing interference with L-glutamate metabolism.
Catalytic Cyclization and Dehydration
In simple terms: The enzyme removes a water molecule from D-glutamate to form a ring-shaped product.
The catalytic mechanism involves the cyclization of D-glutamate to form 5-oxo-D-proline with the release of water. This reaction is a dehydration-cyclization that does not require pyridoxal 5'-phosphate (PLP) or other cofactors, unlike many amino acid racemases and dehydratases. The enzyme likely employs a general acid-base catalysis mechanism, where active site residues facilitate the removal of a water molecule and the formation of the cyclic product. The reaction is reversible, allowing the enzyme to also catalyze the hydration of 5-oxo-D-proline back to D-glutamate under certain conditions.
Cofactor Independence and Metal Requirement
In simple terms: The enzyme does not need the usual vitamin B6 cofactor, but it may use a metal ion.
D-glutamate cyclase is a PLP-independent enzyme, meaning it does not require pyridoxal 5'-phosphate for activity. This is unusual for enzymes that act on amino acids, many of which are PLP-dependent. Although it belongs to the metallo-dependent hydrolase superfamily, the exact metal requirement has not been fully established; however, the superfamily typically contains a divalent metal ion in the active site. The enzyme's activity is not affected by typical PLP inhibitors, confirming its independence from this cofactor.
Kinetic Properties and Regulation
In simple terms: The enzyme works at a certain speed and can be controlled by cellular conditions.
The kinetic parameters of mammalian D-glutamate cyclase have been determined, showing a Km for D-glutamate in the millimolar range and a turnover number that varies by tissue. The enzyme's activity is optimal at neutral to slightly alkaline pH and is sensitive to temperature, with denaturation at high temperatures. Regulation of D-glutamate cyclase activity may occur at the transcriptional level, as its expression varies across tissues, but post-translational modifications have not been extensively studied. The enzyme's activity can be measured using a colorimetric assay that quantifies 5-oxo-D-proline formation, enabling high-throughput screening of potential inhibitors or activators.
Key Genes Involved in GO:0047820 D-glutamate cyclase activity
The following genes and proteins are directly involved in D-glutamate cyclase activity or related D-glutamate metabolic pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DGLUCY | Encodes D-glutamate cyclase, the enzyme responsible for GO:0047820 | Primary target for knockout and overexpression studies |
| DDO | Encodes D-aspartate oxidase, which can also oxidize D-glutamate | Used to distinguish D-glutamate cyclase activity from other D-glutamate-metabolizing enzymes |
| GOT1 | Encodes cytosolic aspartate aminotransferase, involved in glutamate metabolism | May influence D-glutamate levels indirectly |
| GOT2 | Encodes mitochondrial aspartate aminotransferase, involved in glutamate metabolism | Potential cross-talk with D-glutamate metabolism |
| GLUD1 | Encodes glutamate dehydrogenase 1, which metabolizes L-glutamate | May affect D-glutamate levels through L-glutamate pool |
| GLUD2 | Encodes glutamate dehydrogenase 2, primarily in neural tissues | Potential role in D-glutamate homeostasis in brain |
| GLS | Encodes glutaminase, which produces L-glutamate | Indirectly affects D-glutamate availability |
| GLS2 | Encodes glutaminase 2, liver-specific | May influence D-glutamate levels in liver |
| SRR | Encodes serine racemase, which produces D-serine | Related D-amino acid metabolism, potential cross-pathway |
| DAO | Encodes D-amino acid oxidase, which degrades D-amino acids | May compete with D-glutamate cyclase for D-glutamate |
| DAOA | Encodes D-amino acid oxidase activator | Regulates D-amino acid oxidase activity, indirect effect |
| AGXT | Encodes alanine-glyoxylate aminotransferase, involved in glyoxylate metabolism | May affect 5-oxo-D-proline metabolism |
| PHGDH | Encodes phosphoglycerate dehydrogenase, involved in L-serine synthesis | Related to D-serine metabolism, not directly D-glutamate |
| PSAT1 | Encodes phosphoserine aminotransferase, involved in L-serine synthesis | Indirect link to D-amino acid metabolism |
| PSPH | Encodes phosphoserine phosphatase, involved in L-serine synthesis | Indirect link to D-amino acid metabolism |
| SHMT1 | Encodes serine hydroxymethyltransferase 1, involved in one-carbon metabolism | May influence D-glutamate levels via glutamate pools |
| SHMT2 | Encodes serine hydroxymethyltransferase 2, mitochondrial | Potential cross-talk with D-glutamate metabolism |
| MTHFD1 | Encodes methylenetetrahydrofolate dehydrogenase 1 | One-carbon metabolism, indirect effect |
How Is D-glutamate cyclase activity Regulated?
D-glutamate cyclase activity is regulated primarily at the level of gene expression, with tissue-specific differences in mRNA and protein levels. The enzyme's activity can also be modulated by substrate availability and product inhibition, as the reaction is reversible. No specific allosteric regulators or post-translational modifications have been reported, but the enzyme's dependence on metal ions suggests potential regulation by metal homeostasis. Additionally, D-glutamate cyclase activity may be influenced by the presence of other D-amino acid-metabolizing enzymes, such as D-aspartate oxidase, which can compete for D-glutamate.
D-glutamate cyclase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DGLUCY | Neurological disorders (e.g., schizophrenia) | Knockout mouse model to assess D-glutamate levels and behavior |
| DGLUCY | Metabolic disorders | Liver-specific knockout or overexpression in mice |
| DDO | D-glutamate-related neurotoxicity | DDO knockout cells to measure D-glutamate cyclase activity |
| SRR | Schizophrenia | SRR knockout models to study D-serine/D-glutamate cross-talk |
| DAO | Amyotrophic lateral sclerosis | DAO overexpression models to modulate D-amino acid levels |
Neurological Disorders
D-glutamate is a neuromodulator in the mammalian brain, and alterations in its levels have been associated with neurological conditions such as schizophrenia and Alzheimer's disease. D-glutamate cyclase activity, by regulating D-glutamate levels, may play a role in these disorders. However, direct evidence linking D-glutamate cyclase mutations to neurological diseases is currently limited, and further research is needed.
Metabolic Disorders
D-glutamate cyclase is highly expressed in liver and kidney, tissues central to amino acid metabolism. Dysregulation of D-glutamate cyclase activity could contribute to metabolic imbalances, although specific metabolic disorders have not been definitively linked to this enzyme. The enzyme's product, 5-oxo-D-proline, is a metabolite that may have its own biological activities, but these are not well characterized.
Cancer
Altered D-amino acid metabolism has been observed in some cancers, but the role of D-glutamate cyclase in cancer remains largely unexplored. Given its role in D-glutamate homeostasis, it is plausible that D-glutamate cyclase activity could influence tumor metabolism, but no direct studies have been published.
From D-glutamate cyclase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of D-glutamate cyclase loss on D-glutamate levels? | DGLUCY knockout cell line (e.g., HEK293 or HepG2) |
| How does a point mutation in the active site affect enzyme activity? | Point mutation knock-in of DGLUCY (e.g., catalytic residue substitution) |
| Can D-glutamate cyclase be tagged for localization studies? | Knock-in of FLAG- or GFP-tagged DGLUCY |
| What is the effect of D-glutamate cyclase overexpression on cell growth? | DGLUCY overexpression in cancer cell lines |
| Does D-glutamate cyclase interact with other metabolic enzymes? | Knock-in of proximity labeling tags (e.g., BioID) |
| Can D-glutamate cyclase activity be measured in real-time? | Knock-in of a fluorescent reporter for 5-oxo-D-proline |
How to Study the D-glutamate cyclase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Colorimetric assay | 5-oxo-D-proline formation | Measuring D-glutamate cyclase activity in cell lysates |
| CRISPR-Cas9 knockout | Loss of DGLUCY gene function | Studying the effects of enzyme deficiency |
| Overexpression | Increased D-glutamate cyclase levels | Assessing gain-of-function phenotypes |
| Point mutation knock-in | Specific amino acid substitutions | Dissecting catalytic residues |
| Western blot | D-glutamate cyclase protein levels | Validating knockout or overexpression |
| qRT-PCR | DGLUCY mRNA expression | Tissue distribution and regulation |
| LC-MS/MS | D-glutamate and 5-oxo-D-proline levels | Metabolic profiling |
| Immunofluorescence | Subcellular localization of D-glutamate cyclase | Determining organelle targeting |
Colorimetric Assay for D-glutamate Cyclase Activity
A colorimetric assay has been developed to measure D-glutamate cyclase activity by detecting the formation of 5-oxo-D-proline. This method is sensitive and can be used with cell lysates or purified enzyme, making it suitable for high-throughput screening.
CRISPR-Cas9 Knockout for Functional Studies
CRISPR-Cas9 can be used to generate DGLUCY knockout cell lines to study the consequences of loss of D-glutamate cyclase activity on D-glutamate metabolism and cellular phenotypes. Knockout models are essential for determining the enzyme's physiological role.
Overexpression and Point Mutation Models
Overexpression of wild-type or mutant DGLUCY in cell lines allows researchers to study the effects of increased enzyme activity or specific catalytic residues on D-glutamate levels and downstream pathways. Point mutations can be introduced via CRISPR knock-in to dissect the catalytic mechanism.
Proteomics and Metabolomics
Mass spectrometry-based proteomics and metabolomics can be used to quantify D-glutamate cyclase protein levels and D-glutamate/5-oxo-D-proline metabolites in cells and tissues. These methods provide a comprehensive view of the metabolic changes associated with altered enzyme activity.
How CRISPR Can Be Used to Study GO:0047820 D-glutamate cyclase activity
Knockout
CRISPR-Cas9 knockout of DGLUCY is used to completely abolish D-glutamate cyclase activity, allowing researchers to study the consequences of enzyme loss on D-glutamate accumulation and cellular metabolism. Knockout cell lines can be validated by sequencing and Western blot, and then subjected to metabolic assays.
Point Mutation
Point mutations can be introduced into the DGLUCY gene via CRISPR-Cas9 homology-directed repair to substitute key catalytic residues, such as those predicted to be involved in substrate binding or catalysis. These models help dissect the enzymatic mechanism and identify essential amino acids.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) into the endogenous DGLUCY locus enables real-time tracking of enzyme localization and interaction partners without overexpression artifacts. This approach preserves endogenous regulatory elements.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase D-glutamate cyclase levels in cells, allowing researchers to study gain-of-function effects on D-glutamate metabolism and cell physiology. Overexpression models are useful for identifying downstream pathways.
How EDITGENE Supports D-glutamate cyclase activity Research
Researchers studying D-glutamate cyclase activity-related genes often need to determine whether a candidate gene is causally involved in D-glutamate metabolism or associated diseases. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes like DGLUCY and its regulators.
Contact EDITGENE today to design your custom CRISPR model for D-glutamate cyclase activity research.
Frequently Asked Questions About D-glutamate cyclase activity
What is D-glutamate cyclase activity?
D-glutamate cyclase activity (GO:0047820) is the enzyme activity that catalyzes the conversion of D-glutamate to 5-oxo-D-proline and water.
What genes are involved in D-glutamate cyclase activity?
The primary gene is DGLUCY, which encodes the enzyme D-glutamate cyclase. Other genes like DDO and DAO may influence D-glutamate levels indirectly.
What is the reaction catalyzed by D-glutamate cyclase?
The reaction is: D-glutamate = 5-oxo-D-proline + H2O, a reversible dehydration-cyclization.
Where is D-glutamate cyclase expressed?
It is highly expressed in liver, kidney, and heart, with lower levels in other tissues.
Does D-glutamate cyclase require a cofactor?
No, it is a PLP-independent enzyme, unlike many amino acid-metabolizing enzymes.
How can I measure D-glutamate cyclase activity?
A colorimetric assay that detects 5-oxo-D-proline formation is available for measuring activity in biological samples.
What diseases are associated with D-glutamate cyclase?
Alterations in D-glutamate metabolism have been linked to neurological disorders, but direct links to D-glutamate cyclase mutations are still under investigation.
Can I use CRISPR to study D-glutamate cyclase?
Yes, CRISPR knockout, point mutation, and knock-in models can be generated to study the enzyme's function.
What is the difference between D-glutamate cyclase and D-aspartate oxidase?
D-aspartate oxidase can also oxidize D-glutamate but produces a different product; D-glutamate cyclase specifically cyclizes D-glutamate to 5-oxo-D-proline.
How is D-glutamate cyclase activity regulated?
Regulation occurs mainly at the transcriptional level, with tissue-specific expression; no allosteric regulators are known.
Conclusion
D-glutamate cyclase activity (GO:0047820) is a unique PLP-independent enzyme activity that regulates D-glutamate homeostasis by converting it to 5-oxo-D-proline. Its tissue-specific expression and potential links to neurological and metabolic disorders make it an important target for further research. CRISPR-based models, including knockout, point mutation, and knock-in, provide powerful tools to dissect its physiological roles and identify therapeutic opportunities. As the field advances, a deeper understanding of D-glutamate cyclase activity may reveal new insights into D-amino acid biology and disease.
References
- 1. Katane M et al.. 2020. A colorimetric assay method for measuring d-glutamate cyclase activity.. Anal Biochem 605:113838 PMID: 32702438
- 2. Katane M et al.. 2018. Structural and enzymatic properties of mammalian d-glutamate cyclase.. Arch Biochem Biophys 654:10-18 PMID: 30003876
- 3. Katane M et al.. 2020. Identification of an l-serine/l-threonine dehydratase with glutamate racemase activity in mammals.. Biochem J 477(21):4221-4241 PMID: 33079132
- 4. Katane M et al.. 2020. Biochemical characterization of d-aspartate oxidase from Caenorhabditis elegans: its potential use in the determination of free d-glutamate in biological samples.. Biochim Biophys Acta Proteins Proteom 1868(8):140442 PMID: 32376478
